Cardiome Pharma (CRME) Misses Q4 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Cardiome Reports Fourth Quarter and Full Year 2015 Financial Results
March 10, 2016 7:00 AM ESTCardiome to conduct conference call and webcast today, March 10, 2016 at 8:00 a.m. Eastern (5:00 a.m. Pacific)
NASDAQ: CRMEÂ Â Â TSX: COM
VANCOUVER, March 10, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for its fourth quarter and year ended December 31, 2015. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP).
Summary of Operations
Since the beginning of 2015 to date, Cardiome has:
Received BRINAVESSTM... More